| Year |
Citation |
Score |
| 2022 |
Gunasekaran M, Mishra R, Saha P, Morales D, Cheng WC, Jayaraman AR, Hoffman JR, Davidson L, Chen L, Shah AM, Bittle G, Fu X, Tulshyan A, Abdullah M, Kingsbury T, ... Civin C, et al. Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury. Iscience. 25: 104656. PMID 35847554 DOI: 10.1016/j.isci.2022.104656 |
0.328 |
|
| 2020 |
Sei J, Moses B, Becker AH, Kim M, Kaur N, Vemuri M, Civin C. Optimized culture medium for enhanced ex vivo expansion of human hematopoietic stem cells Cytotherapy. 22: S60-S61. DOI: 10.1182/Blood-2019-126174 |
0.398 |
|
| 2019 |
Creed M, Baldeosingh R, Eberly CL, Schlee CS, Kim M, Cutler JA, Pandey A, Civin CI, Fossett NG, Kingsbury TJ. PAX-SIX-EYA-DACH Network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis. Development (Cambridge, England). PMID 31806659 DOI: 10.1242/Dev.177022 |
0.421 |
|
| 2019 |
Kim M, Civin CI, Kingsbury TJ. MicroRNAs as regulators and effectors of hematopoietic transcription factors. Wiley Interdisciplinary Reviews. Rna. e1537. PMID 31007002 DOI: 10.1002/Wrna.1537 |
0.447 |
|
| 2019 |
Kingsbury TJ, Kim M, Civin CI. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network. Advances in Cancer Research. 141: 1-42. PMID 30691681 DOI: 10.1016/Bs.Acr.2018.12.001 |
0.374 |
|
| 2019 |
Creed M, Eberly C, Cutler J, Kim M, Pandey A, Civin CI, Kingsbury TJ. SIX1 Transcription Factor Enhances Human Erythropoiesis Via GATA1 Blood. 134: 3503-3503. DOI: 10.1182/Blood-2019-131203 |
0.45 |
|
| 2019 |
Sei JJ, Moses BS, Harris-Becker A, Kim M, Kaur N, Vemuri MC, Civin CI. Optimized Culture Medium for Enhanced Ex Vivo expansion of Human Hematopoietic Stem Cells Blood. 134: 1965-1965. DOI: 10.1182/blood-2019-126174 |
0.35 |
|
| 2019 |
Mansour SG, Lin P, Pierce A, Civin CI. Use of Multi-Omics Approach to Produce a Robust Serum-Free Media for the Expansion of T Cells Blood. 134: 1053-1053. DOI: 10.1182/Blood-2019-124393 |
0.363 |
|
| 2019 |
Sei J, Moses B, Becker AH, Kim M, Kaur N, Vemuri M, Civin C. StemPro™ HSC expansion medium (Prototype) supports superior expansion of human hematopoietic stem-progenitor cells Cytotherapy. 21: S64-S65. DOI: 10.1016/J.Jcyt.2019.03.448 |
0.48 |
|
| 2018 |
Simpson HM, Furusawa A, Sadashivaiah K, Civin CI, Banerjee A. STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma. Oncotarget. 9: 16792-16806. PMID 29682185 DOI: 10.18632/Oncotarget.24698 |
0.331 |
|
| 2018 |
Moses BS, Fox J, Chen X, McCullough S, Tran SN, Kirkpatrick A, Kumar K, Tyner JW, Posner GH, Civin CI. The 3-Drug Combination Treatment ART838, ABT199 Plus Sorafenib Is Effective Against AML Xenografts, Possibly Via Cooperative Targeting of MCL1 Blood. 132: 4044-4044. DOI: 10.1182/Blood-2018-99-113040 |
0.318 |
|
| 2018 |
Mishra R, Sharma S, Cheng WC, Saha P, Kingsbury TJ, Civin CI, Kaushal S. Abstract 208: miR-34a Regulates the Secretome Production and Functional Potential of Human Cardiac Progenitor Cells by Heat Shock Factor Circulation Research. 123. DOI: 10.1161/Res.123.Suppl_1.208 |
0.348 |
|
| 2017 |
Nieborowska-Skorska M, Sullivan K, Dasgupta Y, Podszywalow-Bartnicka P, Hoser G, Maifrede S, Martinez E, Di Marcantonio D, Bolton-Gillespie E, Cramer-Morales K, Lee J, Li M, Slupianek A, Gritsyuk D, Cerny-Reiterer S, ... ... Civin CI, et al. Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells. The Journal of Clinical Investigation. PMID 28481221 DOI: 10.1172/Jci90825 |
0.374 |
|
| 2017 |
Sasaki T, Rivera-Mulia JC, Vera D, Zimmerman J, Das S, Padget M, Nakamichi N, Chang BH, Tyner J, Druker BJ, Weng AP, Civin CI, Eaves CJ, Gilbert DM. Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia. Experimental Hematology. PMID 28433605 DOI: 10.1016/J.Exphem.2017.04.004 |
0.381 |
|
| 2016 |
Civin CI, Ward T, Skelley AM, Gandhi K, Peilun Lee Z, Dosier CR, D'Silva JL, Chen Y, Kim M, Moynihan J, Chen X, Aurich L, Gulnik S, Brittain GC, Recktenwald DJ, et al. Automated leukocyte processing by microfluidic deterministic lateral displacement. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 27875619 DOI: 10.1002/Cyto.A.23019 |
0.333 |
|
| 2016 |
Zhan T, Cao C, Li L, Gu N, Civin CI, Zhan X. MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4. Leukemia. PMID 26965284 DOI: 10.1038/Leu.2016.39 |
0.36 |
|
| 2016 |
Fox JM, Moynihan JR, Mott BT, Mazzone JR, Anders NM, Brown PA, Rudek MA, Liu JO, Arav-Boger R, Posner GH, Civin CI, Chen X. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. Oncotarget. PMID 26771236 DOI: 10.18632/Oncotarget.6896 |
0.352 |
|
| 2016 |
Kim M, Kingsbury TJ, Civin CI. RAB14 Regulates Human Erythropoiesis and Megakaryopoiesis Blood. 128: 2661-2661. DOI: 10.1182/Blood.V128.22.2661.2661 |
0.476 |
|
| 2016 |
Bai J, Chen X, Civin CI. Nrf2 Regulates Sensitivity of Leukemias to Artemisinins Blood. 128: 2324-2324. DOI: 10.1182/Blood.V128.22.2324.2324 |
0.325 |
|
| 2015 |
Candia J, Cherukuri S, Guo Y, Doshi KA, Banavar JR, Civin CI, Losert W. Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine-learning-driven network approach. Convergent Science Physical Oncology. 1. PMID 27274862 DOI: 10.1088/2057-1739/1/2/025002 |
0.345 |
|
| 2015 |
Furusawa A, Sadashivaiah K, Singh ZN, Civin CI, Banerjee A. Inefficient megakaryopoiesis in mouse hematopoietic stem-progenitor cells lacking T-bet. Experimental Hematology. PMID 26607595 DOI: 10.1016/J.Exphem.2015.11.003 |
0.392 |
|
| 2015 |
Muvarak N, Kelley S, Robert C, Baer MR, Perrotti D, Gambacorti-Passerini C, Civin C, Scheibner K, Rassool FV. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias. Molecular Cancer Research : McR. 13: 699-712. PMID 25828893 DOI: 10.1158/1541-7786.Mcr-14-0422 |
0.344 |
|
| 2015 |
Huang TC, Renuse S, Pinto S, Kumar P, Yang Y, Chaerkady R, Godsey B, Mendell JT, Halushka MK, Civin CI, Marchionni L, Pandey A. Identification of miR-145 targets through an integrated omics analysis. Molecular Biosystems. 11: 197-207. PMID 25354783 DOI: 10.1039/C4Mb00585F |
0.32 |
|
| 2015 |
Kim M, Tan YS, Cheng WC, Kingsbury TJ, Heimfeld S, Civin CI. MIR144 and MIR451 regulate human erythropoiesis via RAB14. British Journal of Haematology. 168: 583-97. PMID 25312678 DOI: 10.1111/Bjh.13164 |
0.352 |
|
| 2015 |
Huang TC, Cutler J, Bharne S, Zhong J, Weinstock D, Tyner J, Gojo I, Civin C, Pandey A. Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target. Leukemia & Lymphoma. 56: 1524-7. PMID 25213184 DOI: 10.3109/10428194.2014.963076 |
0.4 |
|
| 2015 |
Kim M, Kingsbury TJ, Cheng W, Tan YS, Taylor BM, Koshatwar S, Civin CI. RAB14 and RAB5 Gtpases Regulate Human Erythropoiesis, Potentially Via Opposing Roles in Endosomal Recycling Blood. 126: 937-937. DOI: 10.1182/Blood.V126.23.937.937 |
0.47 |
|
| 2014 |
Tan YS, Kim M, Kingsbury TJ, Civin CI, Cheng WC. Regulation of RAB5C is important for the growth inhibitory effects of MiR-509 in human precursor-B acute lymphoblastic leukemia. Plos One. 9: e111777. PMID 25368993 DOI: 10.1371/Journal.Pone.0111777 |
0.367 |
|
| 2014 |
Heiser D, Tan YS, Kaplan I, Godsey B, Morisot S, Cheng WC, Small D, Civin CI. Correlated miR-mRNA expression signatures of mouse hematopoietic stem and progenitor cell subsets predict "Stemness" and "Myeloid" interaction networks. Plos One. 9: e94852. PMID 24747944 DOI: 10.1371/Journal.Pone.0094852 |
0.771 |
|
| 2014 |
Langdon JM, Yates SC, Femnou LK, McCranor BJ, Cheadle C, Xue QL, Vaulont S, Civin CI, Walston JD, Roy CN. Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. American Journal of Hematology. 89: 470-9. PMID 24415655 DOI: 10.1002/Ajh.23670 |
0.303 |
|
| 2014 |
Nieborowska-Skorska M, Sullivan K, Podszywalow-Bartnicka P, Hoser G, Bolton-Gillespie E, Cramer-Morales K, Slupianek A, Zhou C, Cerny-Reiterer S, Stoklosa T, Sykes SM, Valent P, Civin CI, Muschen M, Minden MD, et al. Gene Expression and Mutation Analysis (GEMA) –Guided Precision Medicine Targeting PARP1 to Induce Synthetic Lethality in DNA-PK –Deficient Quiescent and BRCA-Deficient Proliferating Leukemia Stem and Progenitor Cells Blood. 124: 480-480. DOI: 10.1182/Blood.V124.21.480.480 |
0.37 |
|
| 2014 |
Fox JM, Moynihan JR, Posner GH, Brown P, Civin CI, Chen X. Abstract 818: Repurposing Artemisinins for treatment of acute leukemias Cancer Research. 74: 818-818. DOI: 10.1158/1538-7445.Am2014-818 |
0.395 |
|
| 2014 |
Tan YS, Cheng W, Civin CI. Abstract 4788: MiR-509 inhibits human leukemia cell growth Cancer Research. 74: 4788-4788. DOI: 10.1158/1538-7445.Am2014-4788 |
0.413 |
|
| 2014 |
McCranor BJ, Kim MJ, Cruz NM, Xue QL, Berger AE, Walston JD, Civin CI, Roy CN. Corrigendum to Interleukin-6 Directly Impairs the Erythroid Development of Human TF-1 Erythroleukemic Cells [Blood Cells Mol. Dis. 52 (2) (2014)] Blood Cells, Molecules, and Diseases. 52: 236. DOI: 10.1016/J.Bcmd.2014.02.001 |
0.306 |
|
| 2013 |
Cramer-Morales K, Nieborowska-Skorska M, Scheibner K, Padget M, Irvine DA, Sliwinski T, Haas K, Lee J, Geng H, Roy D, Slupianek A, Rassool FV, Wasik MA, Childers W, Copland M, ... ... Civin CI, et al. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood. 122: 1293-304. PMID 23836560 DOI: 10.1182/Blood-2013-05-501072 |
0.339 |
|
| 2013 |
Cheng WC, Kingsbury TJ, Wheelan SJ, Civin CI. A simple high-throughput technology enables gain-of-function screening of human microRNAs. Biotechniques. 54: 77-86. PMID 23384178 DOI: 10.2144/000113991 |
0.341 |
|
| 2013 |
Farrance I, Civin C. Biochemistry and signaling in stem cells, and vice versa. Biochimica Et Biophysica Acta. 1830: 2267. PMID 23331875 DOI: 10.1016/J.Bbagen.2012.12.002 |
0.405 |
|
| 2013 |
Ramalingam S, London V, Kandavelou K, Cebotaru L, Guggino W, Civin C, Chandrasegaran S. Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases. Stem Cells and Development. 22: 595-610. PMID 22931452 DOI: 10.1089/Scd.2012.0245 |
0.433 |
|
| 2013 |
Kim M, Tan YS, Cheng W, Civin CI. MiR-144 and MiR-451 Regulate Human Erythropoiesis By Targeting RAB14 Blood. 122: 942-942. DOI: 10.1182/Blood.V122.21.942.942 |
0.402 |
|
| 2013 |
McCranor BJ, Kim M, Cruz NM, Xue Q, Berger AE, Walston JD, Civin CI, Roy CN. Interleukin-6 Reduces Erythroid Development and Mitochondrial Membrane Potential In Human Erythroleukemic Cells Blood. 122: 3420-3420. DOI: 10.1182/Blood.V122.21.3420.3420 |
0.326 |
|
| 2013 |
Huang T, Bharne SS, Cutler J, Zhong J, Weinstock DM, Tyner JW, Civin CI, Pandey A. Integrated Analysis Of CRLF2 Signaling In Acute Lymphoblastic Leukemia Identifies Polo-Like Kinase 1 As a Therapeutic Target Blood. 122: 2667-2667. DOI: 10.1182/Blood.V122.21.2667.2667 |
0.393 |
|
| 2012 |
Godsey B, Heiser D, Civin C. Inferring microRNA regulation of mRNA with partially ordered samples of paired expression data and exogenous prediction algorithms. Plos One. 7: e51480. PMID 23284698 DOI: 10.1371/Journal.Pone.0051480 |
0.736 |
|
| 2012 |
Scheibner KA, Teaboldt B, Hauer MC, Chen X, Cherukuri S, Guo Y, Kelley SM, Liu Z, Baer MR, Heimfeld S, Civin CI. MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θ. Plos One. 7: e50895. PMID 23236401 DOI: 10.1371/Journal.Pone.0050895 |
0.378 |
|
| 2012 |
Chu SH, Heiser D, Li L, Kaplan I, Collector M, Huso D, Sharkis SJ, Civin C, Small D. FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm. Cell Stem Cell. 11: 346-58. PMID 22958930 DOI: 10.1016/J.Stem.2012.05.027 |
0.777 |
|
| 2012 |
Sharkis SJ, Jones RJ, Civin C, Jang YY. Pluripotent stem cell-based cancer therapy: promise and challenges. Science Translational Medicine. 4: 127ps9. PMID 22461639 DOI: 10.1126/Scitranslmed.3003920 |
0.392 |
|
| 2012 |
Yu D, Zhan XH, Zhao XF, Williams MS, Carey GB, Smith E, Scott D, Zhu J, Guo Y, Cherukuri S, Civin CI, Zhan X. Mice deficient in MIM expression are predisposed to lymphomagenesis Oncogene. 31: 3561-3568. PMID 22081072 DOI: 10.1038/Onc.2011.509 |
0.395 |
|
| 2012 |
Heckel D, Padget M, Cherukuri S, Morisot S, Guo Y, Wayne AS, Brown PA, Civin CI. Abstract 3385: Expression of CD22, a late B lymphoid antigen, does not distinguish leukemia stem cells from the bulk population in acute lymphoblastic leukemia cases Cancer Research. 72: 3385-3385. DOI: 10.1158/1538-7445.Am2012-3385 |
0.515 |
|
| 2011 |
Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL. Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells. Journal of Immunotherapy (Hagerstown, Md. : 1997). 34: 187-95. PMID 21304401 DOI: 10.1097/Cji.0B013E31820D2A21 |
0.367 |
|
| 2011 |
Kaplan IM, Morisot S, Heiser D, Cheng WC, Kim MJ, Civin CI. Deletion of tristetraprolin caused spontaneous reactive granulopoiesis by a non-cell-autonomous mechanism without disturbing long-term hematopoietic stem cell quiescence. Journal of Immunology (Baltimore, Md. : 1950). 186: 2826-34. PMID 21270394 DOI: 10.4049/Jimmunol.1002806 |
0.778 |
|
| 2011 |
Chu SH, Heiser D, Li L, Kaplan IM, Huso D, Civin CI, Small D. FLT3-ITD Knock-in Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to a Myeloproliferative Neoplasm Blood. 118: 46-46. DOI: 10.1182/BLOOD.V118.21.46.46 |
0.79 |
|
| 2010 |
Lebson L, Gocke A, Rosenzweig J, Alder J, Civin C, Calabresi PA, Whartenby KA. Cutting edge: The transcription factor Kruppel-like factor 4 regulates the differentiation of Th17 cells independently of RORγt. Journal of Immunology (Baltimore, Md. : 1950). 185: 7161-4. PMID 21076063 DOI: 10.4049/Jimmunol.1002750 |
0.676 |
|
| 2010 |
Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia. 24: 1859-66. PMID 20739953 DOI: 10.1038/Leu.2010.184 |
0.418 |
|
| 2010 |
Civin CI. CD34 stem cell stories and lessons from the CD34 wars: the Landsteiner Lecture 2009. Transfusion. 50: 2046-56. PMID 20561292 DOI: 10.1111/J.1537-2995.2010.02729.X |
0.409 |
|
| 2010 |
Scheibner KA, Heiser D, Kaplan IM, Cheng W, Kim M, Bharne SS, Morisot S, Civin CI. MicroRNA Maestros of Hematopoiesis Blood. 116: SCI-32-SCI-32. DOI: 10.1182/Blood.V116.21.Sci-32.Sci-32 |
0.751 |
|
| 2010 |
Layman AJ, Langdon JM, Yu Q, Prince OD, Walston JD, Civin CI, Roy CN. Shortened Erythrocyte Life Span and Increased Oxidative Stress In Erythroid Precursors Are Consistent with Normocytic Anemia In Mice with Chronic Inflammation Blood. 116: 3205-3205. DOI: 10.1182/Blood.V116.21.3205.3205 |
0.301 |
|
| 2010 |
Scheibner KA, Teaboldt B, Hauer MC, Civin CI. The Mir-23a∼Mir-27a∼Mir-24 Cluster Acts as a Tumor Suppressor In Leukemias by Post-Transcriptional Regulation of 14-3-3 Proteins Blood. 116: 3145-3145. DOI: 10.1182/Blood.V116.21.3145.3145 |
0.347 |
|
| 2010 |
Cheng W, Bohana-Kashtan O, Morisot S, Zhang N, Chen Q, Pan D, Civin CI. The YAP Transcriptional Co-Activator Is Not Required for Mouse Hematopoiesis, at Steady State or After 5FU Treatment. Blood. 116: 1592-1592. DOI: 10.1182/Blood.V116.21.1592.1592 |
0.496 |
|
| 2010 |
Heiser D, Chu SH, Li L, Kaplan IM, Civin CI, Small D. Sorafenib Treatment Reverses Depletion of Primitive Hematopoietic Stem Cells and Resolves FLT3-ITD Driven Myeloproliferative Disease In a Mouse Model. Blood. 116: 1586-1586. DOI: 10.1182/Blood.V116.21.1586.1586 |
0.803 |
|
| 2010 |
Mussai FJ, Campana D, Bhojwani D, Stetler-Stevenson M, Steinberg SM, Morisot S, Civin CI, Wayne AS, Pastan I. Abstract 4356: Cytotoxicity of the anti-CD22 immunotoxin HA22 against pediatric acute lymphoblastic leukemia (ALL) Cancer Research. 70: 4356-4356. DOI: 10.1158/1538-7445.Am10-4356 |
0.438 |
|
| 2009 |
Kandavelou K, Ramalingam S, London V, Mani M, Wu J, Alexeev V, Civin CI, Chandrasegaran S. Targeted manipulation of mammalian genomes using designed zinc finger nucleases. Biochemical and Biophysical Research Communications. 388: 56-61. PMID 19635463 DOI: 10.1016/J.Bbrc.2009.07.112 |
0.325 |
|
| 2009 |
Bohana-Kashtan O, Morisot S, Hildreth R, Brayton C, Levitsky HI, Civin CI. Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand. Journal of Immunology (Baltimore, Md. : 1950). 183: 696-705. PMID 19535642 DOI: 10.4049/Jimmunol.0800561 |
0.458 |
|
| 2009 |
Kaplan IM, Morisot S, Heiser D, Cheng W, LaDana C, Civin CI. The Hematopoietic Stem Cell (HSC) Compartment in Tristetraprolin (TTP) Knock-out Mice Is Abnormal Phenotypically but Normal Functionally. Blood. 114: 2541-2541. DOI: 10.1182/Blood.V114.22.2541.2541 |
0.777 |
|
| 2009 |
Chu SH, Heiser D, Li L, Kaplan IM, Civin CI, Small D. FLT3 Internal Tandem Duplication (ITD) Mutations Disrupt Homeostasis in Hematopoietic Stem Cells. Blood. 114: 1420-1420. DOI: 10.1182/Blood.V114.22.1420.1420 |
0.802 |
|
| 2008 |
Yu X, Zou J, Ye Z, Hammond H, Chen G, Tokunaga A, Mali P, Li YM, Civin C, Gaiano N, Cheng L. Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. Cell Stem Cell. 2: 461-71. PMID 18462696 DOI: 10.1016/J.Stem.2008.03.001 |
0.412 |
|
| 2008 |
Alder JK, Georgantas RW, Hildreth RL, Kaplan IM, Morisot S, Yu X, McDevitt M, Civin CI. Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo. Journal of Immunology (Baltimore, Md. : 1950). 180: 5645-52. PMID 18390749 DOI: 10.1182/Blood.V110.11.239.239 |
0.731 |
|
| 2008 |
Prince OD, Prince IC, Walston J, Andrews NC, Civin CI, Roy CN. Inhibited Maturation of Ter119+CD71+ Erythroid Precursors in Mice with Chronic Sterile Abscess. Blood. 112: 3844-3844. DOI: 10.1182/Blood.V112.11.3844.3844 |
0.325 |
|
| 2008 |
Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Hildreth R, Brown P, Stetler-Stevenson M, Civin CI. Leukemia Stem Cells (LSCs) Are Frequent in Childhood Precursor B Acute Lymphoblastic Leukemia (ALL). Blood. 112: 1354-1354. DOI: 10.1182/Blood.V112.11.1354.1354 |
0.428 |
|
| 2007 |
Georgantas RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proceedings of the National Academy of Sciences of the United States of America. 104: 2750-5. PMID 17293455 DOI: 10.1073/Pnas.0610983104 |
0.658 |
|
| 2007 |
Morisot S, Hildreth R, Kaplan IM, Stetler-Stevenson M, Taylor JA, Ahuja Y, Bloom L, Wayne AS, Civin CI. Sensitive NOD-scid-IL2γnull (NOG-scid) Assay for Human Precursor B Acute Lymphoblastic Leukemias (ALL). Blood. 110: 4286-4286. DOI: 10.1182/Blood.V110.11.4286.4286 |
0.445 |
|
| 2007 |
Bohana-Kashtan O, Levitsky H, Civin CI. Identification of New Alloantigen-Reactive CD8+ Cytotoxic and Suppressor T Cell Subpopulations. Blood. 110: 3229-3229. DOI: 10.1182/Blood.V110.11.3229.3229 |
0.411 |
|
| 2006 |
McNiece I, Civin C, Harrington J, Kellner JN, Malehorn M, Turney J, Barber J, Jones R. Ex vivo expansion of mafosfamide-purged PBPC products Cytotherapy. 8: 459-464. PMID 17050250 DOI: 10.1080/14653240600905353 |
0.479 |
|
| 2006 |
Wang D, D'Costa J, Civin CI, Friedman AD. C/EBPalpha directs monocytic commitment of primary myeloid progenitors. Blood. 108: 1223-9. PMID 16645168 DOI: 10.1182/Blood-2005-12-008763 |
0.316 |
|
| 2006 |
Civin CI, Rao MS. How many human embryonic stem cell lines are sufficient? A U.S. perspective. Stem Cells (Dayton, Ohio). 24: 800-3. PMID 16543487 DOI: 10.1634/Stemcells.2006-0084 |
0.392 |
|
| 2006 |
Yu X, Alder JK, Chun JH, Friedman AD, Heimfeld S, Cheng L, Civin CI. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells (Dayton, Ohio). 24: 876-88. PMID 16513761 DOI: 10.1634/Stemcells.2005-0598 |
0.729 |
|
| 2006 |
Civin CI. Stem Cells' Impact Continues Its Ascent Stem Cells. 24: 1993-1994. DOI: 10.1634/Stemcells.2006-0443 |
0.43 |
|
| 2006 |
Kashtan O, Levitsky HI, Civin CI. Ex Vivo Fas Ligand Treatment Selectively Eliminates T Cells That Mediate GVHD. Blood. 108: 3167-3167. DOI: 10.1182/Blood.V108.11.3167.3167 |
0.431 |
|
| 2006 |
Zambidis ET, Jokubaitis VJ, Tam A, Sinka L, Civin CI, Tavian M, Simmons PJ, Peault B. Angiotensin-Converting Enzyme (ACE) Expression Defines the Earliest Primitive and Definitive Lympho-Hematopoietic Progenitors Derived from Human Embryonic Stem Cells. Blood. 108: 1662-1662. DOI: 10.1182/Blood.V108.11.1662.1662 |
0.482 |
|
| 2006 |
Hildreth R, Georgantas RW, Patel R, Morisot S, Alder J, Civin CI. MicroRNA hsa-mir-16 Contributes to Regulation of Myeloid Differentiation of Human CD34+ Cells. Blood. 108: 1343-1343. DOI: 10.1182/Blood.V108.11.1343.1343 |
0.707 |
|
| 2006 |
D’Costa J, Friedman AD, Civin CI. Enforced RUNX1 Expression Increased the Numbers of CD34+ and CD45+ Cells from Human Embryonic Stem Cell-Derived Embryoid Bodies. Blood. 108: 1340-1340. DOI: 10.1182/Blood.V108.11.1340.1340 |
0.49 |
|
| 2006 |
Georgantas RW, Hildreth R, Morisot S, Alder J, Civin CI. MicroRNA hsa-mir-155 Blocks Myeloid and Erythroid Differentiation of Human CD34+ Cells. Blood. 108: 1337-1337. DOI: 10.1182/Blood.V108.11.1337.1337 |
0.704 |
|
| 2006 |
Georgantas RW, Hildreth R, Alder J, Croce CM, Calin GA, Civin CI. MicroRNA Expression and Regulation of Hematopoiesis in CD34+ Cells: A Bioinformatic Circuit Diagram of the Hematopoietic Differentiation Control. Blood. 108: 1334-1334. DOI: 10.1182/Blood.V108.11.1334.1334 |
0.715 |
|
| 2006 |
Alder JK, Georgantas RW, Hildreth RL, Yu X, Civin CI. Kruppel-Like Factor 4 Upregulates p21 and Downregulates Proliferation of Human and Mouse HSPCs, but Is Not Essential for Mouse HSPC Repopulation. Blood. 108: 1317-1317. DOI: 10.1182/Blood.V108.11.1317.1317 |
0.728 |
|
| 2006 |
Bohana-Kashtan O, Levitsky HI, Civin CI. 770. Selective Elimination of Alloreactive GVHD-Mediating Donor T Cells by Ex Vivo sFasL Treatment Molecular Therapy. 13: S298. DOI: 10.1016/J.Ymthe.2006.08.855 |
0.43 |
|
| 2006 |
Alder JK, Georgantas RW, Hildreth RL, Civin CI. 348. Kruppel-Like Factor 4 Regulates Proliferation of Human and Mouse Hematopoietic Stem-Progenitor Cells, but Is Not Essential for Mouse Hematopoietic Repopulation Molecular Therapy. 13: S132-S133. DOI: 10.1016/J.Ymthe.2006.08.406 |
0.746 |
|
| 2006 |
Morisot S, Georgantas RW, Civin CI. 345. Hematopoietic Stem-Progenitor Cells Express CD52 mRNA and Membrane Protein Molecular Therapy. 13: S131-S132. DOI: 10.1016/J.Ymthe.2006.08.403 |
0.474 |
|
| 2006 |
D'Costa J, Friedman AD, Zambidis E, Civin CI. 342. RUNX1 Increases Proliferation of Embryoid Bodies Derived from Human Embryonic Stem Cells Molecular Therapy. 13: S130. DOI: 10.1016/J.Ymthe.2006.08.400 |
0.413 |
|
| 2006 |
Georgantas RW, Bohana-Kashtan O, Civin CI. 1041. Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease Molecular Therapy. 82: 471-478. DOI: 10.1016/J.Ymthe.2006.08.1137 |
0.41 |
|
| 2005 |
Topaloglu O, Hurley PJ, Yildirim O, Civin CI, Bunz F. Improved methods for the generation of human gene knockout and knockin cell lines. Nucleic Acids Research. 33: e158. PMID 16214806 DOI: 10.1093/Nar/Gni160 |
0.341 |
|
| 2005 |
Zambidis ET, Peault B, Park TS, Bunz F, Civin CI. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood. 106: 860-70. PMID 15831705 DOI: 10.1182/Blood-2004-11-4522 |
0.494 |
|
| 2005 |
D'Costa J, Chaudhuri S, Civin CI, Friedman AD. CBFbeta-SMMHC slows proliferation of primary murine and human myeloid progenitors. Leukemia. 19: 921-9. PMID 15815715 DOI: 10.1038/Sj.Leu.2403755 |
0.463 |
|
| 2005 |
Civin CI, Gewirtz AM, Hawley RG, Goodell MA. Advancing the fast-paced field of stem cell research: stem cells increases from 6 to 10 issues in its 23rd year of publication. Stem Cells (Dayton, Ohio). 23: 1-2. PMID 15625117 DOI: 10.1634/Stemcells.2005-Ed.1 |
0.406 |
|
| 2005 |
Zambidis ET, Osborne J, Civin CI. Generation of a Common Progenitor Population from Human Embryonic Stem Cells That Gives Rise to Both Embryonic Erythropoiesis and Definitive Hematopoiesis. Blood. 106: 521-521. DOI: 10.1182/Blood.V106.11.521.521 |
0.5 |
|
| 2005 |
Wang D, D’Costa J, Civin CI, Friedman . AD. Exogenous C/EBPα Favors the Monocytic Commitment and Maturation of Normal Murine Myeloid Progenitors. Blood. 106: 2711-2711. DOI: 10.1182/Blood.V106.11.2711.2711 |
0.416 |
|
| 2005 |
Civin CI. The wizard of Hox Blood. 106: 3682-3683. DOI: 10.1182/Blood-2005-09-3688 |
0.383 |
|
| 2004 |
Topaloglu O, Civin CI, Bunz F. Digital HLA allelotyping. Cancer Biology & Therapy. 3: 899-902. PMID 15326386 DOI: 10.4161/Cbt.3.9.1083 |
0.346 |
|
| 2004 |
Esni F, Ghosh B, Biankin AV, Lin JW, Albert MA, Yu X, MacDonald RJ, Civin CI, Real FX, Pack MA, Ball DW, Leach SD. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development (Cambridge, England). 131: 4213-24. PMID 15280211 DOI: 10.1242/Dev.01280 |
0.427 |
|
| 2004 |
Georgantas RW, Tanadve V, Malehorn M, Heimfeld S, Chen C, Carr L, Martinez-Murillo F, Riggins G, Kowalski J, Civin CI. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Research. 64: 4434-41. PMID 15231652 DOI: 10.1158/0008-5472.Can-03-3247 |
0.479 |
|
| 2004 |
Palaganas J, Civin CI. Two steps forward: keeping the momentum in stem cell research. Stem Cells (Dayton, Ohio). 22: 240-1. PMID 15153598 DOI: 10.1634/Stemcells.22-3-240 |
0.396 |
|
| 2004 |
Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ. Characterization of clonogenic multiple myeloma cells. Blood. 103: 2332-6. PMID 14630803 DOI: 10.1182/Blood-2003-09-3064 |
0.458 |
|
| 2004 |
Civin CI. STEM CELLS: Some Good News Stem Cells. 22: 648-648. DOI: 10.1634/Stemcells.22-5-648 |
0.423 |
|
| 2004 |
Civin CI. Whither Stem Cells? Stem Cells. 22: 1127-1127. DOI: 10.1634/Stemcells.2004-Ed12 |
0.445 |
|
| 2004 |
Alder JK, Georgantas RW, Yu X, Civin CI. KLF4 as a Mediator of Quiescence in Hematopoietic Stem/Progenitor Cells. Blood. 104: 4146-4146. DOI: 10.1182/Blood.V104.11.4146.4146 |
0.757 |
|
| 2004 |
Zambidis ET, Peault B, Bunz F, Civin CI. Embryonic Erythropoiesis and Definitive Hematopoiesis from Human Embryonic Stem Cells Is Regulated by Cytokines Controlling HSC Growth. Blood. 104: 2777-2777. DOI: 10.1182/Blood.V104.11.2777.2777 |
0.412 |
|
| 2004 |
D’Costa J, Chaudhuri S, Civin CI, Friedman AD. CBFβ-SMMHC Inhibits G1 to S Progression in Primary Murine and Human Myeloid Progenitors Dependent upon Its AML1-Interaction and Assembly Competence Domains. Blood. 104: 1971-1971. DOI: 10.1182/Blood.V104.11.1971.1971 |
0.478 |
|
| 2003 |
Yu X, Zhan X, D'Costa J, Tanavde VM, Ye Z, Peng T, Malehorn MT, Yang X, Civin CI, Cheng L. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 827-38. PMID 12788657 DOI: 10.1016/S1525-0016(03)00104-7 |
0.411 |
|
| 2003 |
Cui Y, Kelleher E, Straley E, Fuchs E, Gorski K, Levitsky H, Borrello I, Civin CI, Schoenberger SP, Cheng L, Pardoll DM, Whartenby KA. Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells. Nature Medicine. 9: 952-8. PMID 12778137 DOI: 10.1038/Nm882 |
0.381 |
|
| 2003 |
Angelopoulou M, Novelli E, Grove JE, Rinder HM, Civin C, Cheng L, Krause DS. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Experimental Hematology. 31: 413-20. PMID 12763140 DOI: 10.1016/S0301-472X(03)00042-0 |
0.483 |
|
| 2003 |
Gorin NC, Piantadosi S, Stull M, Bonte H, Wingard JR, Civin C. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood. Journal of Hematotherapy & Stem Cell Research. 11: 277-92. PMID 11983099 DOI: 10.1089/152581602753658466 |
0.446 |
|
| 2003 |
Civin CI, Gewirtz AM, Hawley RG. Stem Cells: 21 Years Old, With the Best Yet to Come Stem Cells. 21: 513-513. DOI: 10.1634/Stemcells.21-5-513 |
0.397 |
|
| 2002 |
Bernardin F, Yang Y, Civin CI, Friedman AD. c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoprotein. Cancer Biology & Therapy. 1: 492-6. PMID 12496475 DOI: 10.4161/Cbt.1.5.163 |
0.355 |
|
| 2002 |
Roesler J, Brenner S, Bukovsky AA, Whiting-Theobald N, Dull T, Kelly M, Civin CI, Malech HL. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease. Blood. 100: 4381-90. PMID 12393624 DOI: 10.1182/Blood-2001-12-0165 |
0.458 |
|
| 2002 |
Chute JP, Saini AA, Chute DJ, Wells MR, Clark WB, Harlan DM, Park J, Stull MK, Civin C, Davis TA. Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow Blood. 100: 4433-4439. PMID 12393435 DOI: 10.1182/Blood-2002-04-1238 |
0.495 |
|
| 2002 |
Whartenby KA, Straley EE, Kim H, Racke F, Tanavde V, Gorski KS, Cheng L, Pardoll DM, Civin CI. Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation. Blood. 100: 3147-54. PMID 12384412 DOI: 10.1182/Blood-2002-01-0118 |
0.453 |
|
| 2002 |
Lumkul R, Gorin NC, Malehorn MT, Hoehn GT, Zheng R, Baldwin B, Small D, Gore S, Smith D, Meltzer PS, Civin CI. Human AML cells in NOD/SCID mice: engraftment potential and gene expression. Leukemia. 16: 1818-26. PMID 12200698 DOI: 10.1038/Sj.Leu.2402632 |
0.453 |
|
| 2002 |
Tanavde VM, Malehorn MT, Lumkul R, Gao Z, Wingard J, Garrett ES, Civin CI. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Experimental Hematology. 30: 816-23. PMID 12135681 DOI: 10.1016/S0301-472X(02)00818-4 |
0.452 |
|
| 2002 |
Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsà V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, et al. CD antigens 2002. Blood. 99: 3877-80. PMID 12014373 DOI: 10.1182/Blood.V99.10.3877 |
0.331 |
|
| 2002 |
Kim H, Whartenby KA, Georgantas RW, Wingard J, Civin CI. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis. Stem Cells (Dayton, Ohio). 20: 174-82. PMID 11897874 DOI: 10.1634/Stemcells.20-2-174 |
0.363 |
|
| 2002 |
Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsà V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, et al. Reference: CD Antigens 2002. Journal of Immunology (Baltimore, Md. : 1950). 168: 2083-6. PMID 11859091 DOI: 10.4049/Jimmunol.168.5.2083 |
0.335 |
|
| 2002 |
Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsà V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, et al. CD Antigens 2001. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 15: 71-6. PMID 11796844 DOI: 10.1189/Jlb.70.5.685 |
0.319 |
|
| 2002 |
Civin CI, Gewirtz AM. Stem Cells 20th Anniversary Stem Cells. 20: 1-2. DOI: 10.1634/Stemcells.20-1-1 |
0.419 |
|
| 2001 |
Mason DY, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsà V, Meuer S, Morissey J, Schwartz-Albiez R, Shaw S, et al. CD antigens 2001. Tissue Antigens. 58: 425-30. PMID 11929596 DOI: 10.1034/j.1399-0039.2001.580614.x |
0.304 |
|
| 2001 |
Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsà V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, et al. CD antigens 2001. European Journal of Immunology. 31: 2841-7. PMID 11592058 DOI: 10.1002/1521-4141(2001010)31:10<2841::Aid-Immu2841>3.0.Co;2-Y |
0.307 |
|
| 2001 |
Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsà V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, et al. CD antigens 2001. Cellular Immunology. 211: 81-5. PMID 11591111 DOI: 10.1006/Cimm.2001.1831 |
0.307 |
|
| 2001 |
Civin CI. Stem cell research: back to the future. Stem Cells (Dayton, Ohio). 19: 356-7. PMID 11553844 DOI: 10.1634/Stemcells.19-5-356 |
0.398 |
|
| 2001 |
Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsà V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, et al. CD antigens 2001. Immunology. 103: 401-6. PMID 11529929 DOI: 10.1046/J.1365-2567.2001.01295.X |
0.307 |
|
| 2001 |
Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsà V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, et al. CD antigens 2001. International Immunology. 13: 1095-8. PMID 11526089 DOI: 10.1093/Intimm/13.9.1095 |
0.419 |
|
| 2001 |
Gao Z, Fackler MJ, Leung W, Lumkul R, Ramirez M, Theobald N, Malech HL, Civin CI. Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- cell preparations. Experimental Hematology. 29: 910-21. PMID 11438214 DOI: 10.1016/S0301-472X(01)00654-3 |
0.458 |
|
| 2001 |
Felschow DM, McVeigh ML, Hoehn GT, Civin CI, Fackler MJ. The adapter protein CrkL associates with CD34. Blood. 97: 3768-75. PMID 11389015 DOI: 10.1182/Blood.V97.12.3768 |
0.351 |
|
| 2001 |
Gao Z, Golob J, Tanavde VM, Civin CI, Hawley RG, Cheng L. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Stem Cells (Dayton, Ohio). 19: 247-59. PMID 11359950 DOI: 10.1634/Stemcells.19-3-247 |
0.476 |
|
| 2001 |
Civin CI. Hematopoietic Stem Cell Therapy. Journal of Pediatric Hematology/Oncology. 23: 474. DOI: 10.1097/00043426-200110000-00018 |
0.409 |
|
| 2000 |
Civin CI. Human pluripotent stem cells: science fiction poses no immediate dangers. Stem Cells (Dayton, Ohio). 18: IV-V. PMID 11072037 DOI: 10.1634/Stemcells.18-6-0-Iv |
0.422 |
|
| 2000 |
Felschow DM, Civin CI, Hoehn GT. Characterization of the tyrosine kinase Tnk1 and its binding with phospholipase C-gamma1. Biochemical and Biophysical Research Communications. 273: 294-301. PMID 10873601 DOI: 10.1006/Bbrc.2000.2887 |
0.403 |
|
| 2000 |
Novelli EM, Cheng L, Yang Y, Leung W, Ramírez M, Tanavde V, Enger C, Civin CI. Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency. Human Gene Therapy. 10: 2927-40. PMID 10609654 DOI: 10.1089/10430349950016348 |
0.479 |
|
| 2000 |
Mosca J, Mbalaviele G, Liu L, Lee K, Novelli E, Civin C, Deans R. Support of human CD34 + cell engraftment in nod/scid mice Experimental Hematology. 28: 71. DOI: 10.1016/S0301-472X(00)00309-X |
0.482 |
|
| 1999 |
Novelli EM, Ramírez M, Leung W, Civin CI. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice. Stem Cells (Dayton, Ohio). 17: 242-52. PMID 10527459 DOI: 10.1002/Stem.170242 |
0.413 |
|
| 1999 |
Leung W, Ramírez M, Mukherjee G, Perlman EJ, Civin CI. Comparisons of alloreactive potential of clinical hematopoietic grafts. Transplantation. 68: 628-35. PMID 10507480 DOI: 10.1097/00007890-199909150-00006 |
0.361 |
|
| 1999 |
Leung W, Ramírez M, Civin CI. Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 5: 69-76. PMID 10371358 DOI: 10.1053/Bbmt.1999.V5.Pm10371358 |
0.485 |
|
| 1999 |
Leung W, Blakemore K, Jones RJ, Moser HW, Mukherjee G, Griffin CA, Rosenblum-Vos LS, Civin CI. A human-murine chimera model for in utero human hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 5: 1-7. PMID 10232735 DOI: 10.1053/Bbmt.1999.V5.Pm10232735 |
0.382 |
|
| 1999 |
Liu C, Levenstein M, Chen J, Tsifrina E, Yonescu R, Griffin C, Civin CI, Small D. SZF1: A novel KRAB-zinc finger gene expressed in CD34+ stem/progenitor cells Experimental Hematology. 27: 313-325. PMID 10029171 DOI: 10.1016/S0301-472X(98)00035-6 |
0.494 |
|
| 1999 |
Novelli EM, Ramirez M, Civin CI. Biology of CD34+CD38- cells in lymphohematopoiesis. Leukemia & Lymphoma. 31: 285-93. PMID 9869192 DOI: 10.3109/10428199809059221 |
0.43 |
|
| 1998 |
Leung W, Chen AR, Klann RC, Moss TJ, Davis JM, Noga SJ, Cohen KJ, Friedman AD, Small D, Schwartz CL, Borowitz MJ, Wharam MD, Paidas CN, Long CA, Karandish S, ... ... Civin CI, et al. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplantation. 22: 971-9. PMID 9849694 DOI: 10.1038/Sj.Bmt.1701471 |
0.372 |
|
| 1998 |
Britos-Bray M, Ramirez M, Cao W, Wang X, Liu PP, Civin CI, Friedman AD. CBFβ-SMMHC, Expressed in M4eo Acute Myeloid Leukemia, Reduces p53 Induction and Slows Apoptosis in Hematopoietic Cells Exposed to DNA-Damaging Agents Blood. 92: 4344-4352. DOI: 10.1182/Blood.V92.11.4344.423A01_4344_4352 |
0.339 |
|
| 1998 |
Götze KS, Ramı́rez M, Tabor K, Small D, Matthews W, Civin CI. Flt3high and Flt3low CD34+Progenitor Cells Isolated From Human Bone Marrow Are Functionally Distinct Blood. 91: 1947-1958. DOI: 10.1182/Blood.V91.6.1947 |
0.474 |
|
| 1996 |
Civin CI, Trischmann T, Kadan NS, Davis J, Noga S, Cohen K, Duffy B, Groenewegen I, Wiley J, Law P, Hardwick A, Oldham F, Gee A. Highly purified CD34-positive cells reconstitute hematopoiesis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 14: 2224-33. PMID 8708711 DOI: 10.1200/Jco.1996.14.8.2224 |
0.423 |
|
| 1996 |
Civin CI, Small D. Purification and expansion of human hematopoietic stem/progenitor cells. Annals of the New York Academy of Sciences. 770: 91-8. PMID 8597386 DOI: 10.1111/J.1749-6632.1995.Tb31046.X |
0.523 |
|
| 1996 |
Civin C, Almeida-Porada G, Lee M, Olweus J, Terstappen L, Zanjani E. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo Blood. 88: 4102-4109. DOI: 10.1182/Blood.V88.11.4102.Bloodjournal88114102 |
0.499 |
|
| 1996 |
Carow C, Levenstein M, Kaufmann S, Chen J, Amin S, Rockwell P, Witte L, Borowitz M, Civin C, Small D. Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemias Blood. 87: 1089-1096. DOI: 10.1182/Blood.V87.3.1089.Bloodjournal8731089 |
0.454 |
|
| 1995 |
Carow CE, Kim E, Hawkins AL, Webb HD, Griffin CA, Jabs EW, Civin CI, Small D. Localization of the human stem cell tyrosine kinase-1 gene (FLT3) to 13q12→q13 Cytogenetic and Genome Research. 70: 255-257. PMID 7789184 DOI: 10.1159/000134046 |
0.412 |
|
| 1995 |
Fackler M, Krause D, Smith O, Civin C, May W. Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells Blood. 85: 3040-3047. DOI: 10.1182/Blood.V85.11.3040.Bloodjournal85113040 |
0.455 |
|
| 1994 |
Trischmann TM, Schepers KG, Civin CI. Measurement of CD34+ cells in bone marrow by flow cytometry. Journal of Hematotherapy. 2: 305-13. PMID 7522885 DOI: 10.1089/Scd.1.1993.2.305 |
0.386 |
|
| 1993 |
Civin CI, Gore SD. Antigenic analysis of hematopoiesis: A review Journal of Hematotherapy. 2: 137-144. PMID 7522876 DOI: 10.1089/Scd.1.1993.2.137 |
0.444 |
|
| 1992 |
Kuerbitz SJ, Civin CI, Krischer JP, Ravindranath Y, Steuber CP, Weinstein HJ, Winick N, Ragab AH, Gresik MV, Crist WM. Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 10: 1419-29. PMID 1517785 DOI: 10.1200/Jco.1992.10.9.1419 |
0.326 |
|
| 1992 |
Scott L, Civin C, Rorth P, Friedman A. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells Blood. 80: 1725-1735. DOI: 10.1182/Blood.V80.7.1725.Bloodjournal8071725 |
0.325 |
|
| 1992 |
Silvestri F, Banavali S, Yin M, Hulette B, Gopal V, Civin CI, Baccarani M, Preisler HD. CD34 antigen expression of acute myeloid leukemia-colony forming cells The International Journal of Cell Cloning. 10: 98-100. DOI: 10.1002/Stem.5530100733 |
0.432 |
|
| 1992 |
Civin CI. Purified progenitor/The International Journal of Cell Cloning: Background, feasibility, and prospects for clinical transplantation The International Journal of Cell Cloning. 10: 16-19. DOI: 10.1002/Stem.5530100707 |
0.438 |
|
| 1991 |
Kurihara N, Civin C, Roodman GD. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 6: 257-61. PMID 2035352 DOI: 10.1002/Jbmr.5650060307 |
0.353 |
|
| 1991 |
Silvestri FF, Banavali SD, Hulette BC, Civin CI, Preisler HD. Isolation and characterization of the CD34+ hematopoietic progenitor cells from the peripheral blood of patients with chronic myeloid leukemia. International Journal of Cell Cloning. 9: 474-90. PMID 1720155 DOI: 10.1002/Stem.1991.5530090505 |
0.451 |
|
| 1991 |
Banavali S, Silvestri F, Hulette B, Hurtubise P, Srivastava A, Civin CI, Preisler HD. Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia. Leukemia Research. 15: 603-8. PMID 1713638 DOI: 10.1016/0145-2126(91)90029-S |
0.376 |
|
| 1991 |
Strauss LC, Trischmann TM, Rowley SD, Wiley JM, Civin CI. Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. The American Journal of Pediatric Hematology/Oncology. 13: 217-21. PMID 1712550 DOI: 10.1097/00043426-199122000-00018 |
0.498 |
|
| 1991 |
Geller RB, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Piantadosi S, Civin CI. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10) British Journal of Haematology. 76: 340-7. PMID 1702006 DOI: 10.1111/J.1365-2141.1990.Tb06365.X |
0.378 |
|
| 1991 |
Gore S, Kastan M, Civin C. Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells Blood. 77: 1681-1690. DOI: 10.1182/Blood.V77.8.1681.Bloodjournal7781681 |
0.441 |
|
| 1990 |
Gore SD, Kastan MB, Goodman SN, Civin CI. Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry. Journal of Immunological Methods. 132: 275-86. PMID 1698878 DOI: 10.1016/0022-1759(90)90039-X |
0.41 |
|
| 1990 |
Borowitz MJ, Shuster JJ, Civin CI, Carroll AJ, Look AT, Behm FG, Land VJ, Pullen DJ, Crist WM. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 8: 1389-98. PMID 1696310 DOI: 10.1200/Jco.1990.8.8.1389 |
0.373 |
|
| 1990 |
Sharkis S, Jones R, Bellis M, Demetri G, Griffin J, Civin C, May W. The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors Blood. 76: 716-720. DOI: 10.1182/Blood.V76.4.716.716 |
0.425 |
|
| 1990 |
Ema H, Suda T, Nagayoshi K, Miura Y, Civin C, Nakauchi H. Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils Blood. 76: 1956-1961. DOI: 10.1182/Blood.V76.10.1956.Bloodjournal76101956 |
0.391 |
|
| 1990 |
Kastan M, Schlaffer E, Russo J, Colvin O, Civin C, Hilton J. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells Blood. 75: 1947-1950. DOI: 10.1182/Blood.V75.10.1947.Bloodjournal75101947 |
0.46 |
|
| 1990 |
Kastan M, Schlaffer E, Russo J, Colvin O, Civin C, Hilton J. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells Blood. 75: 1947-1950. DOI: 10.1182/blood.v75.10.1947.1947 |
0.356 |
|
| 1989 |
Loken MR, Shah VO, Hollander Z, Civin CI. Flow cytometric analysis of normal B lymphoid development. Pathology and Immunopathology Research. 7: 357-70. PMID 3266012 DOI: 10.1159/000157129 |
0.432 |
|
| 1989 |
Civin CI. Reducing the cost of the cure in childhood leukemia. The New England Journal of Medicine. 321: 185-7. PMID 2747749 DOI: 10.1056/Nejm198907203210309 |
0.311 |
|
| 1989 |
Kastan M, Stone K, Civin C. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells Blood. 74: 1517-1524. DOI: 10.1182/Blood.V74.5.1517.Bloodjournal7451517 |
0.441 |
|
| 1989 |
Kastan M, Slamon D, Civin C. Expression of protooncogene c-myb in normal human hematopoietic cells Blood. 73: 1444-1451. DOI: 10.1182/Blood.V73.6.1444.Bloodjournal7361444 |
0.466 |
|
| 1989 |
Kastan M, Slamon D, Civin C. Expression of protooncogene c-myb in normal human hematopoietic cells Blood. 73: 1444-1451. DOI: 10.1182/blood.v73.6.1444.1444 |
0.362 |
|
| 1988 |
Hurwitz C, Loken M, Graham M, Karp J, Borowitz M, Pullen D, Civin C. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia Blood. 72: 299-307. DOI: 10.1182/Blood.V72.1.299.Bloodjournal721299 |
0.407 |
|
| 1988 |
Hollander Z, Shah V, Civin C, Loken M. Assessment of proliferation during maturation of the B lymphoid lineage in normal human bone marrow Blood. 71: 528-531. DOI: 10.1182/Blood.V71.2.528.528 |
0.426 |
|
| 1987 |
Schwartz CL, Minniti CP, Harwood P, Na S, Banquerigo ML, Strauss LC, Kurtzberg J, Smith SD, Civin CI. Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 5: 1900-11. PMID 3500279 DOI: 10.1200/Jco.1987.5.12.1900 |
0.383 |
|
| 1987 |
Civin CI, Loken MR. Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. International Journal of Cell Cloning. 5: 267-88. PMID 3305726 DOI: 10.1002/Stem.5530050403 |
0.447 |
|
| 1987 |
Loken M, Civin C, Bigbee W, Langlois R, Jensen R. Coordinate glycosylation and cell surface expression of glycophorin A during normal human erythropoiesis Blood. 70: 1959-1961. DOI: 10.1182/Blood.V70.6.1959.1959 |
0.363 |
|
| 1987 |
Loken M, Shah V, Dattilio K, Civin C. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development Blood. 70: 1316-1324. DOI: 10.1182/Blood.V70.5.1316.Bloodjournal7051316 |
0.44 |
|
| 1987 |
Loken M, Shah V, Dattilio K, Civin C. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development Blood. 70: 1316-1324. DOI: 10.1182/blood.V70.5.1316.bloodjournal7051316 |
0.331 |
|
| 1987 |
Loken M, Shah V, Dattilio K, Civin C. Flow cytometric analysis of human bone marrow: I. Normal erythroid development Blood. 69: 255-263. DOI: 10.1182/Blood.V69.1.255.Bloodjournal691255 |
0.422 |
|
| 1987 |
Loken M, Shah V, Dattilio K, Civin C. Flow cytometric analysis of human bone marrow: I. Normal erythroid development Blood. 69: 255-263. DOI: 10.1182/blood.V69.1.255.bloodjournal691255 |
0.31 |
|
| 1986 |
McMillan EM, Humphrey GB, Stoneking L, Strauss LC, Civin CI, Abo T, Balch C. Analysis of histiocytosis X infiltrates with monoclonal antibodies directed against cells of histiocytic, lymphoid, and myeloid lineage. Clinical Immunology and Immunopathology. 38: 295-301. PMID 3510787 DOI: 10.1016/0090-1229(86)90239-4 |
0.334 |
|
| 1986 |
Noga SJ, Cremo CA, Duff SC, Schwartz CL, Melaragno A, Civin CI, Donnenberg AD. Large scale separation of human bone marrow by counterflow centrifugation elutriation. Journal of Immunological Methods. 92: 211-8. PMID 2944969 DOI: 10.1016/0022-1759(86)90168-7 |
0.372 |
|
| 1986 |
Noga SJ, Donnenberg AD, Schwartz CL, Strauss LC, Civin CI, Santos GW. Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow. Transplantation. 41: 220-9. PMID 2935979 DOI: 10.1097/00007890-198602000-00017 |
0.387 |
|
| 1985 |
Leary AG, Ogawa M, Strauss LC, Civin CI. Single cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes. The Journal of Clinical Investigation. 74: 2193-7. PMID 6511923 DOI: 10.1172/JCI111645 |
0.372 |
|
| 1985 |
Leary A, Strauss L, Civin C, Ogawa M. Disparate differentiation in hemopoietic colonies derived from human paired progenitors Blood. 66: 327-332. DOI: 10.1182/blood.V66.2.327.bloodjournal662327 |
0.35 |
|
| 1985 |
Leary A, Strauss L, Civin C, Ogawa M. Disparate differentiation in hemopoietic colonies derived from human paired progenitors Blood. 66: 327-332. DOI: 10.1182/blood.v66.2.327.327 |
0.35 |
|
| 1984 |
Strauss L, Skubitz K, August J, Civin C. Antigenic analysis of hematopoiesis: II. Expression of human neutrophil antigens on normal and leukemic marrow cells Blood. 63: 574-578. DOI: 10.1182/Blood.V63.3.574.574 |
0.425 |
|
| 1983 |
Strauss L, Stuart R, Civin C. Antigenic analysis of hematopoiesis. I. Expression of the My-1 granulocyte surface antigen on human marrow cells and leukemic cell lines Blood. 61: 1222-1231. DOI: 10.1182/blood.v61.6.1222.bloodjournal6161222 |
0.31 |
|
| 1982 |
Mirro J, Schwartz JF, Civin CI. Simultaneous analysis of cell surface antigens and cell morphology using monoclonal antibodies conjugated to fluorescent microspheres. Journal of Immunological Methods. 47: 39-48. PMID 7031139 DOI: 10.1016/0022-1759(81)90255-6 |
0.395 |
|
| 1982 |
Luk GD, Civin CI, Weissman RM, Baylin SB. Ornithine decarboxylase: essential in proliferation but not differentiation of human promyelocytic leukemia cells. Science (New York, N.Y.). 216: 75-7. PMID 6950518 DOI: 10.1126/Science.6950518 |
0.448 |
|
| 1981 |
Civin C, Mirro J, Banquerigo M. My-1, new myeloid-specific antigen identified by a mouse monoclonal antibody Blood. 57: 842-845. DOI: 10.1182/Blood.V57.5.842.842 |
0.395 |
|
| Show low-probability matches. |